Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
News Focus
Voyageur Secures First International Sales Contract worth US$1.9 Million (click to learn more)
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Sona Nanotech Inc C.SONA

Alternate Symbol(s):  SNANF

Technology Scientific & Technical Instruments
Sona Nanotech Inc. is a nanotechnology life sciences company that has developed multiple methods for the manufacturing of various types of gold nanoparticles. The Company is engaged in the research and development of its technology for use in multiplex diagnostic testing platforms and biomedical applications. Its gold nanotechnologies are adapted for use in applications, as a safe and delivery system for multiple medical treatments, for the approval of various regulatory boards, including Health Canada and the Food and Drug administration (FDA). Its gold nanorod particles are manufactured without the use of CTAB (cetyltrimethylammonium), eliminating the toxicity risks associated with the use of other gold nanorod technologies in medical applications. The Company leverages its core proprietary gold nanorod (GNR) manufacturing technology and laboratory assets to focus on the development of diagnostic tests and biologic reagents, and the advancement of its GNR intellectual property.


CSE:SONA - Post by User

Sona Nanotech Inc > Newsfile link Sona Engages Sports Marketing Partner to Secur
<< Previous
 Bullboard Posts
Next >>
User Avatar Image
(1010)
•••
Post by shoosh22on Aug 31, 2020 8:38am
193 Views
Post# 31478354

Newsfile link Sona Engages Sports Marketing Partner to Secur

Newsfile link Sona Engages Sports Marketing Partner to SecurWintrader I couldn't open the Market Herald link so reposting from Newsfile.....Wow A NR already. A global Concussion Test.   Sona beginning to line up participants in Field Study to develop new prototype for a test which tests MTMI Mild Tramatic Brain Injury..  Concussion.  What Sports around the world is crying for.  To test immediately following a head injury a test which will determine is one has indeed suffer a Concussion.They are being upfront that from now until FDA Submission will be 12-24 months... but nice we have something tangible 'a test' after Covid 19.  In the world of sports it is imperative to track and monitor head injuries.  This will be huge... I Love Sona... this company never ceases to surprise.  GLTA  &  FDA HC submissions complete... 


https://www.newsfilecorp.com/release/62859/Sona-Engages-Sports-Marketing-Partner-to-Secure-Concussion-Test-Development-Partner
<< Previous
 Bullboard Posts
Next >>
Dealroom for high-potential pre-IPO opportunities